NCT06646614

Brief Summary

The proposed research aims to engage participants in group educational sessions to facilitate learning of topics related to advanced care planning and to determine whether this approach is more effective than usual care alone.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable cancer

Timeline
14mo left

Started Jul 2025

Typical duration for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress51%
Jul 2025Dec 2027

First Submitted

Initial submission to the registry

October 15, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 17, 2024

Completed
9 months until next milestone

Study Start

First participant enrolled

July 15, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 16, 2026

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Expected
Last Updated

August 19, 2026

Status Verified

August 1, 2026

Enrollment Period

1 year

First QC Date

October 15, 2024

Last Update Submit

August 16, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Goals of Care Documentation

    Documentation of goals of care discussions will be analyzed for each patient at 8 weeks after patient enrollment.

    Month 2 after patient enrollment

Secondary Outcomes (6)

  • Feeling Heard and Understood

    Baseline and Month 2 after patient enrollment

  • Change in patient activation using the Patient Activation Measure

    Baseline and Month 2 after patient enrollment

  • Change in patient satisfaction with decision using the Satisfaction with Decision Measure

    Baseline and Month 2 after patient enrollment

  • Palliative Care Use (Self-reported and Chart Review)

    At Baseline and Month 6 after patient enrollment

  • Hospice Care Use (Self-reported and Chart Review)

    At Baseline and Month 6 after patient enrollment

  • +1 more secondary outcomes

Study Arms (2)

Usual Care

NO INTERVENTION

The patient will continue to receive as normal and usual care. The participant will also receive educational materials in writing regarding advance care planning mailed to their preferred mailing address. The participants will complete surveys and interviews at baseline at again at 2 months post-enrollment.

Group Advance Care Planning

EXPERIMENTAL

The participant will receive normal and usual care which also consists of educational materials in writing regarding advance care planning mailed to their preferred mailing address. They will also engage in 2 group educational sessions with 4-5 participants which will last 60-90 minutes regarding advance care planning. They participants will complete surveys and interviews at baseline and again at 2 months post-enrollment.

Behavioral: Group Advance Care Planning Education

Interventions

Those assigned to the group ACP arm will receive usual care and the intervention which consists of 2 virtual or in-person 60-90 minute sessions by a trained community health worker/health educator. Sessions will introduce advanced care planning, help veterans discuss their goals of care with their care teams and learn how to discuss with their families and oncologist, and filing an advanced directive. Participants will be surveyed and interviewed at baseline and again at 2 months post-enrollment.

Group Advance Care Planning

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients \>18 years old with newly diagnosed cancer are eligible.
  • Patients must have the ability to understand and willingness to provide verbal consent
  • Participants must speak English

You may not qualify if:

  • Inability to consent to the study
  • Plans to move within the area and leave the VA system within 4 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA Palo Alto

Palo Alto, California, 94305, United States

Location

MeSH Terms

Conditions

Neoplasms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The statistician analyzing the data will be masked from the experimental treatment and the control as will all research staff who are abstracting or collecting outcomes data.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Staff Physician

Study Record Dates

First Submitted

October 15, 2024

First Posted

October 17, 2024

Study Start

July 15, 2025

Primary Completion

July 16, 2026

Study Completion (Estimated)

December 1, 2027

Last Updated

August 19, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

We will not share.

Locations